Cardiorenalmetabolic

Latest News

Hamlet Gasoyan, PhD
Improve Antiobesity Medication Adherence to Improve Results: Hamlet Gasoyan, PhD

June 26th 2025

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic.

Cardiologist listening to patient's heart | Image credit: Space_Cat – stock.adobe.com
40% of Patients With Heart Failure Don’t See Cardiologist Annually, Increasing Risk of Death

June 19th 2025

Hamlet Gasoyan, PhD
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD

June 19th 2025

CBD oils and hemp leaves | Image credit: Irina_Evva – stock.adobe.com
CBD-Based Drug Shows No Heart Safety Risks in Patients With CVD or Risk Factors

May 23rd 2025

AJMC
Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

May 16th 2025

More News

Familial Hypercholesterolemia | Image credit: Richelle – stock.adobe.com
September 23rd 2024

A Decade of Progress in Familial Hypercholesterolemia Awareness, Treatment

Hayden E. Klein
On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing significant strides made in the field over the past decade.
The authors’ overall estimate of the current national prevalence of AF is at least 10.55 million individuals—more than 3 times what prior research estimated. | Image credit: Robert -stock.adobe.com
September 12th 2024

New Estimates Suggest Atrial Fibrillation 3 Times More Common Than Thought

Rose McNulty
New prevalence estimates of atrial fibrillation found that approximately 10.5 million US adults, or 5% of the population, have the condition.
AJMC
September 5th 2024

Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes

Keith A. Betts, PhD Nikolaus G. Oberprieler, PhD, MSc, MBA Aozhou Wu, PhD Glen James, PhD Scott Beeman, PharmD Alain Gay, MD Xuanhao He, PhD David Vizcaya, PhD, MPH
This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
dr ian neeland
September 5th 2024

Comprehensive Care: The Key to Managing Diabetes and Its Complexities

Brooke McCormick
Ian Neeland, MD, of University Hospitals and Case Western Reserve University, recommended a team-based, comprehensive approach to managing diabetes and its related complications.
dr manisha jhamb
September 4th 2024

UPMC's Dr Manisha Jhamb Urges Better Kidney Disease Awareness, Integrated Care

Brooke McCormick
Manisha Jhamb, MD, MPH, of the University of Pittsburgh Medical Center (UPMC), is excited about CMS's negotiated drug prices under the Inflation Reduction Act (IRA) for patients with kidney disease; conversely, she highlights the challenge of low kidney disease awareness.
Hot dogs with ketchup and mustard | Image credit: Mediteraneo – stock.adobe.com
September 4th 2024

Meat Consumption and Increased Diabetes Risk: Building on the Current Evidence Base

Hayden E. Klein
New findings add to the relationship between red meat and processed meat consumption and the risk of type 2 diabetes.
Inclisiran's twice-yearly cadence and physician administration have potential to improve adherence to treatment, which is a common challenge with cholesterol management. Image credit: Robert - stock.adobe.com
August 30th 2024

Inclisiran Significantly Lowers LDL-C in V-MONO Study

Rose McNulty
Twice-yearly inclisiran (Leqvio) monotherapy showed clinically meaningful and statistically significant LDL-C lowering in patients at low or moderate risk of atherosclerotic cardiovascular disease in the V-MONO study.
Doctor holding a heart | Image credit: Pana Studio - stock.adobe.com
August 30th 2024

Lipid-Lowering Therapies Beyond Statins: ESC 2024

Laura Joszt, MA
Research at the European Society of Cardiology Congress 2024 evaluated lipid-lowering therapy beyond statins alone in patients with high levels of low-density lipoprotein cholesterol.
Stethoscope around a red heart | Image credit: eggeeggjiew - adobe.stock.com
August 30th 2024

SGLT Inhibitors for Heart Failure by Duration of Diabetes: ESC 2024

Laura Joszt, MA
Regardless of duration of type 2 diabetes, sodium-glucose cotransporter inhibitors prevented cardiovascular events, according to research presented at the European Society of Cardiology Congress 2024.
CGM | Image credit: Andrey Popov – stock.adobe.com
Published: August 27th 2024 | Updated: August 27th 2024

FDA Expands Omnipod 5 AID System Label to Treat Type 2 Diabetes

Hayden E. Klein
The expanded approval for the Omnipod 5 system now allows automated insulin delivery (AID) for adults with type 2 diabetes, offering a new option for better glucose management without daily injections.
Red, yellow, and green trees reflecting memory loss or recovery | Image credit: freshidea – stock.adobe.com
August 27th 2024

SGLT2 Inhibitors, GLP-1 Agonists Similarly Reduce Dementia Risk for Patients With Diabetes

Hayden E. Klein
New findings add to the pile of research on the possible neuroprotective effects of drugs like dapagliflozin, empagliflozin, and dulaglutide for patients with type 2 diabetes.
Wegovy injections and packaging | Image credit: Ole – stock.adobe.com
August 24th 2024

Patients With Heart Failure May Benefit From Weight Loss Drug

Hayden E. Klein
New research indicates that the heart benefits of semaglutide can extend to those with heart failure.
Hospital building | Image credit: Spiroview Inc. – stock.adobe.com
August 23rd 2024

Postdischarge Mortality Remains Unchanged Despite Advances in Heart Failure Care

Hayden E. Klein
Heart failure mortality rates after hospital discharge have seen little improvement since 2010 among Medicare beneficiaries, with real-world outcomes falling short of clinical trial expectations.
Jose A. Martinez, MD
August 20th 2024

Choosing the Right Treatment Path for Diabetic Macular Edema

Hayden E. Klein
Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach.
Using Telemedicine to Expand Diabetic Retinopathy Screening
August 16th 2024

Using Telemedicine to Expand Diabetic Retinopathy Screening

Hayden E. Klein
Despite guidelines recommending annual screenings, nearly half of patients with diabetes miss critical eye exams, explains Jose A. Martinez, MD, president and retina specialist at Austin Retina Associates.
Electrocardiogram in hospital surgery operating emergency room | Image credit: totojang1977 – stock.adobe.com
August 15th 2024

Surgery Improves Outcomes for Patients With Atrial Functional Mitral Regurgitation

Hayden E. Klein
A new study found that older patients with atrial functional mitral regurgitation who underwent mitral valve surgery had significantly better outcomes than those who received medical management alone, including lower rates of heart failure hospitalization and death.
Wegovy injections | Image credit: K KStock – stock.adobe.com
August 6th 2024

Rising Costs Lead Insurers to Drop Weight Loss Drug Coverage, Further Increasing Patient Burden

Hayden E. Klein
The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still struggling to meet their goals.
AJMC Q&A with Dr Martha Gulati | Background image credit: ipopba – stock.adobe.com
August 2nd 2024

In ASPC President’s Address, Dr Martha Gulati Reflects on Progress and Future Goals in Cardiology

Hayden E. Klein
Martha Gulati, MD, MS, discusses the accomplishments of the American Society of Preventive Cardiology (ASPC) during her presidency and emphasizes the importance of advancing preventive cardiology.
Robert Kushner, MD, MS
August 2nd 2024

GLP-1 Agonists and the Gut-Brain Axis: A New Era in Obesity Management

Hayden E. Klein
“We are at an inflection point regarding treatment of obesity,” said Robert Kushner, MD, MS, Northwestern University Feinberg School of Medicine.
Michael Shapiro, DO, FASPC, Wake Forest University and ASPC president elect
July 31st 2024

ASPC Congress to Highlight Innovations in CVD Prevention

Maggie L. Shaw
In advance of this year’s American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention, we spoke with ASPC President-Elect Michael Shapiro, DO, FASPC, about the many can't-miss sessions at this year's record-breaking event.
concept of heart issues-ArtemisDiana-stock.adobe.com.jpeg
July 29th 2024

Applying PREVENT Equations May Reduce Statin and Antihypertensive Therapy for 15.8 Million US Adults

Pearl Steinzor
Researchers identify potential reductions in statin and antihypertensive therapy eligibility using Predicting Risk of cardiovascular disease EVENTs (PREVENT) equations.
Patient using a smartwatch | Image Credit: sitthiphong - stock.adobe.com
July 20th 2024

Wearable Devices Heighten Symptom Monitoring, Health Care Visits for Atrial Fibrillation

Brooke McCormick
Patients with atrial fibrillation who use wearable devices, like Apple Watches and FitBits, report higher anxiety levels and increased health care usage than nonusers.
FDA | Image credit: Araki Illustrations – stock.adobe.com
July 18th 2024

FDA Grants Breakthrough Device Designation to ContraBand System to Treat HFrEF

Hayden E. Klein
The catheter-delivered implant uses the right ventricle to support the left, improving left ventricle ejection fraction and helping restore the heart’s normal shape.
US and Japan flags | Image credit: Oleksii – stock.adobe.com
July 18th 2024

Key Differences in Heart Failure Management, Outcomes Between US and Japan

Hayden E. Klein
A new study revealed longer heart failure hospital stays, better 30-day follow-up, and lower mortality rates in Japan compared with the US.
Older woman sleeping with clock on nightstand | Image credit: Pixel-Shot – stock.adobe.com
July 17th 2024

Inconsistent Sleep May Heighten Older Adults’ Risk of Diabetes

Hayden E. Klein
Older adults with the most irregular sleep durations demonstrated a 34% higher risk of developing type 2 diabetes compared with those with the most regular sleep.
Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com
July 15th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Pearl Steinzor
No significant differences in efficacy or safety of 2 aspirin doses were found between male and female patients for the secondary prevention of atherosclerotic cardiovascular disease (ASCVD).
Salt and salt shaker | Image credit: Melica – stock.adobe.com
July 15th 2024

Lowering Sodium Intake Reduces AF Risk, but Does Not Improve Heart Failure Outcomes

Hayden E. Klein
New studies say restricting salt intake can reduce the risk of atrial fibrillation (AF) in certain patients, but cannot reduce the risks of morbidity and death in patients with heart failure.
What We’re Reading: Change Cyberattack Exposes Personal Data; Ozempic May Reduce Dementia Risk; Rural Hospitals Shutdown
July 15th 2024

What We’re Reading: Cyberattack Exposes Personal Data; Semaglutide May Reduce Dementia Risk; Rural Hospitals Shutdown

AJMC Staff
Up to one-third of Americans have been affected by data stolen through the Change Healthcare cyberattack; research highlights potential cognitive and psychiatric benefits of semaglutide; over 40 Iowa hospitals have ended their labor and delivery services.
ASPC Congress Logo
July 8th 2024

2024 ASPC Congress on CVD Prevention to Be Held in August

Maggie L. Shaw
The American Society for Preventive Cardiology (ASPC) 2024 Congress on CVD Prevention will take place August 2-4 in Salt Lake City, Utah.
Kathryn Lindley, MD, FACC – Vanderbilt University Medical Center
July 5th 2024

How Vanderbilt's Women's Heart Center Is Bridging the Gender Gap in Heart Health

Hayden E. Klein
Kathryn Lindley, MD, FACC, Vanderbilt University Medical Center, emphasizes the importance of bringing heart health care to patients and meeting them where they are.
<12345>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo